These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30991063)

  • 21. Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine.
    Pouriayevali MH; Bamdad T; Sadat SM; Sadeghi SA; Sabahi F; Mahdavi M; Aghasadeghi MR
    IUBMB Life; 2019 Oct; 71(10):1645-1652. PubMed ID: 31298809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listeriolysin O Causes ENaC Dysfunction in Human Airway Epithelial Cells.
    Yang G; Pillich H; White R; Czikora I; Pochic I; Yue Q; Hudel M; Gorshkov B; Verin A; Sridhar S; Isales CM; Eaton DC; Hamacher J; Chakraborty T; Lucas R
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29439494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphocholine Antagonizes Listeriolysin O-Induced Host Cell Responses of Listeria monocytogenes.
    La Pietra L; Hudel M; Pillich H; Abu Mraheil M; Berisha B; Aden S; Hodnik V; Lochnit G; Rafiq A; Perniss A; Anderluh G; Chakraborty T
    J Infect Dis; 2020 Oct; 222(9):1505-1516. PubMed ID: 31970394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directly Observing the Lipid-Dependent Self-Assembly and Pore-Forming Mechanism of the Cytolytic Toxin Listeriolysin O.
    Mulvihill E; van Pee K; Mari SA; Müller DJ; Yildiz Ö
    Nano Lett; 2015 Oct; 15(10):6965-73. PubMed ID: 26302195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes.
    Kohda C; Kawamura I; Baba H; Nomura T; Ito Y; Kimoto T; Watanabe I; Mitsuyama M
    Infect Immun; 2002 Mar; 70(3):1334-41. PubMed ID: 11854218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.
    Taheri A; Dinarvand R; Atyabi F; Ahadi F; Nouri FS; Ghahremani MH; Ostad SN; Borougeni AT; Mansoori P
    Int J Mol Sci; 2011; 12(7):4591-608. PubMed ID: 21845098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism.
    Sibelius U; Chakraborty T; Krögel B; Wolf J; Rose F; Schmidt R; Wehland J; Seeger W; Grimminger F
    J Immunol; 1996 Nov; 157(9):4055-60. PubMed ID: 8892639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo.
    Nitcheu-Tefit J; Dai MS; Critchley-Thorne RJ; Ramirez-Jimenez F; Xu M; Conchon S; Ferry N; Stauss HJ; Vassaux G
    J Immunol; 2007 Aug; 179(3):1532-41. PubMed ID: 17641019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Listeriolysin O-induced stimulation of mucin exocytosis in polarized intestinal mucin-secreting cells: evidence for toxin recognition of membrane-associated lipids and subsequent toxin internalization through caveolae.
    Coconnier MH; Lorrot M; Barbat A; Laboisse C; Servin AL
    Cell Microbiol; 2000 Dec; 2(6):487-504. PubMed ID: 11207603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers.
    Roy J; Kaake M; Srinivasarao M; Low PS
    Bioconjug Chem; 2018 Jul; 29(7):2208-2214. PubMed ID: 29851465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering BinB Pore-Forming Toxin for Selective Killing of Breast Cancer Cells.
    Kumkoon T; Noree C; Boonserm P
    Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological effects of listeriolysin O: implications for vaccination.
    Hernández-Flores KG; Vivanco-Cid H
    Biomed Res Int; 2015; 2015():360741. PubMed ID: 25874208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein.
    Giammarini C; Andreoni F; Amagliani G; Casiere A; Barocci S; Magnani M
    Protein Expr Purif; 2003 Mar; 28(1):78-85. PubMed ID: 12651110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation.
    Portman JL; Huang Q; Reniere ML; Iavarone AT; Portnoy DA
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.
    Kim NH; Provoda C; Lee KD
    Mol Pharm; 2015 Feb; 12(2):342-50. PubMed ID: 25521817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophils.
    Arnett E; Vadia S; Nackerman CC; Oghumu S; Satoskar AR; McLeish KR; Uriarte SM; Seveau S
    J Immunol; 2014 Jan; 192(1):234-44. PubMed ID: 24319266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH dependence of listeriolysin O aggregation and pore-forming ability.
    Bavdek A; Kostanjšek R; Antonini V; Lakey JH; Dalla Serra M; Gilbert RJ; Anderluh G
    FEBS J; 2012 Jan; 279(1):126-41. PubMed ID: 22023160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.
    Arencibia JM; Schally AV; Halmos G; Nagy A; Kiaris H
    Anticancer Drugs; 2001 Jan; 12(1):71-8. PubMed ID: 11272290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Listeriolysin O Pore-Forming Activity Is Required for ERK1/2 Phosphorylation During
    Cheng C; Sun J; Yu H; Ma T; Guan C; Zeng H; Zhang X; Chen Z; Song H
    Front Immunol; 2020; 11():1146. PubMed ID: 32582211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.